Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by...

  • 1665761710764851205 Profile photo of Madelyn

    Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday. https://t.co/qsSMXqYuHm - view on twitter

Mashup Score:12

Reuters

US FDA approves Pfizer’s RSV vaccine - 1 week

Mashup Score:12

The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc’s respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot...

  • 1664097114568237056 Profile photo of Madelyn

    The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors. https://t.co/W3vZWnUMk9 - view on twitter

Mashup Score:11

Reuters

US FDA approves Pfizer’s RSV vaccine - 1 week

Mashup Score:11

The U.S. Food and Drug Administration (FDA) on Wednesday approved Pfizer Inc’s respiratory syncytial virus (RSV) vaccine for older adults, making it the second...

  • 1664032847751938048 Profile photo of Madelyn

    The U.S. Food and Drug Administration (FDA) on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors. https://t.co/usLfcYrkGB - view on twitter

Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by...

  • 1665697611527880713 Profile photo of Madelyn

    Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday. https://t.co/I2jPPadS28 - view on twitter

AstraZeneca’s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who...

  • 1665331568741588992 Profile photo of Madelyn

    AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed. https://t.co/v9tGALp6VY - view on twitter

BioNTech said on Friday that a new cancer immunotherapy candidate that it is working on with U.S. partner OncoC4 Inc was shown to shrink...

  • 1664588306749829120 Profile photo of Madelyn

    BioNTech said on Friday that a new cancer immunotherapy candidate that it is working on with U.S. partner OncoC4 Inc was shown to shrink tumours in close to 30% of participants in a mid-stage lung cancer trial. https://t.co/SlM1yo7S1m - view on twitter

AstraZeneca’s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who...

  • 1665459744323039233 Profile photo of Madelyn

    AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed. https://t.co/1MuEtWP9hy - view on twitter

Novartis breast cancer drug Kisqali cut the risk of recurrence by a little more than 25% in a pivotal trial on women diagnosed at...

  • 1664606638639030272 Profile photo of Madelyn

    Novartis breast cancer drug Kisqali cut the risk of recurrence by a little more than 25% in a pivotal trial on women diagnosed at an early stage, positioning the Swiss drugmaker to win new patients and challenging strong rival Eli Lilly . https://t.co/fDY9phAlxy - view on twitter

AstraZeneca’s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who...

  • 1665395581160763395 Profile photo of Madelyn

    AstraZeneca's lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed early enough to have their tumour surgically removed, trial data showed. https://t.co/doxvFjXOFA - view on twitter

Adding an experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread by 65% over treatment...

  • 1665825888708034564 Profile photo of Madelyn

    Adding an experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a trial. https://t.co/A8tuOkcoZO - view on twitter